These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38720423)

  • 21. [THE ROLE OF SEMAPHORIN 7A IN SYSTEMIC SCLEROSIS].
    Rimar D; Slobodin G; Rosner I; Rozenbaum M; Kaly L; Boulman N; Jiries N; Awisat A; Vadasz Z
    Harefuah; 2017 Jul; 156(7):418-421. PubMed ID: 28786275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype.
    Mathai SK; Gulati M; Peng X; Russell TR; Shaw AC; Rubinowitz AN; Murray LA; Siner JM; Antin-Ozerkis DE; Montgomery RR; Reilkoff RA; Bucala RJ; Herzog EL
    Lab Invest; 2010 Jun; 90(6):812-23. PubMed ID: 20404807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-6 and Type-I Collagen Production by Systemic Sclerosis Fibroblasts Are Differentially Regulated by Interleukin-17A in the Presence of Transforming Growth Factor-Beta 1.
    Dufour AM; Alvarez M; Russo B; Chizzolini C
    Front Immunol; 2018; 9():1865. PubMed ID: 30150989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of thalidomide on Th17, Treg cells and TGF-β1/Smad3 pathway in a mouse model of systemic sclerosis.
    Lu Y; Zhao C; Lei L; Tao Z; Zheng L; Wen J; Li X
    Int J Rheum Dis; 2020 Mar; 23(3):406-419. PubMed ID: 31840939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease.
    Valenzi E; Bulik M; Tabib T; Morse C; Sembrat J; Trejo Bittar H; Rojas M; Lafyatis R
    Ann Rheum Dis; 2019 Oct; 78(10):1379-1387. PubMed ID: 31405848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
    Meloni F; Caporali R; Marone Bianco A; Paschetto E; Morosini M; Fietta AM; Patrizio V; Bobbio-Pallavicini F; Pozzi E; Montecucco C
    Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):111-8. PubMed ID: 15281432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathways.
    Hsu E; Feghali-Bostwick CA
    Am J Pathol; 2008 Jun; 172(6):1580-90. PubMed ID: 18467708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
    Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
    Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of the transforming growth factor β-inducible gene HIC-5 in systemic sclerosis skin and fibroblasts: a novel antifibrotic therapeutic target.
    Piera-Velazquez S; Fertala J; Huaman-Vargas G; Louneva N; Jiménez SA
    Rheumatology (Oxford); 2020 Oct; 59(10):3092-3098. PubMed ID: 32442272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloid cell-specific deletion of Capns1 prevents macrophage polarization toward the M1 phenotype and reduces interstitial lung disease in the bleomycin model of systemic sclerosis.
    Zhang L; Zheng D; Yan Y; Yu Y; Chen R; Li Z; Greer PA; Peng T; Wang Q
    Arthritis Res Ther; 2022 Jun; 24(1):148. PubMed ID: 35729674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An essential role for CCAAT/enhancer binding protein beta in bleomycin-induced pulmonary fibrosis.
    Hu B; Ullenbruch MR; Jin H; Gharaee-Kermani M; Phan SH
    J Pathol; 2007 Mar; 211(4):455-62. PubMed ID: 17177178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis.
    Del Galdo F; Sotgia F; de Almeida CJ; Jasmin JF; Musick M; Lisanti MP; Jiménez SA
    Arthritis Rheum; 2008 Sep; 58(9):2854-65. PubMed ID: 18759267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [AMP-activated kinase activation inhibits transforming growth factor-β1 production in cardiac fibroblasts via targeting C/EBPβ].
    Xiao H; Piao CS; Chen RF; Zhang YY
    Sheng Li Xue Bao; 2017 Apr; 69(2):123-128. PubMed ID: 28435970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
    Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
    Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated Fibronectin Levels in Profibrotic CD14
    Rudnik M; Hukara A; Kocherova I; Jordan S; Schniering J; Milleret V; Ehrbar M; Klingel K; Feghali-Bostwick C; Distler O; Błyszczuk P; Kania G
    Front Immunol; 2021; 12():642891. PubMed ID: 34504485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF-β-mediated upregulation of brachyury contributes to constitutively up-regulated type I collagen expression in skin fibroblasts: possible role in systemic sclerosis.
    Teng L; Yao G; Gao R; Wang Y; Lin W; Jin Y; Wang Y; Chen H; Wang Z; Chen J
    Eur J Dermatol; 2019 Aug; 29(4):359-365. PubMed ID: 31625918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chitinase 1 is a biomarker for and therapeutic target in scleroderma-associated interstitial lung disease that augments TGF-β1 signaling.
    Lee CG; Herzog EL; Ahangari F; Zhou Y; Gulati M; Lee CM; Peng X; Feghali-Bostwick C; Jimenez SA; Varga J; Elias JA
    J Immunol; 2012 Sep; 189(5):2635-44. PubMed ID: 22826322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KL6 and IL-18 levels are negatively correlated with respiratory function tests and ILD extent assessed on HRCT in patients with systemic sclerosis-related interstitial lung disease (SSc-ILD).
    Sieiro Santos C; Antolín SC; Lorenzo JC; Garay CL; Morales CM; de Miguel EB; Guerrero MR; Herránz LS; Álvarez ED
    Semin Arthritis Rheum; 2024 Apr; 65():152366. PubMed ID: 38290372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
    Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptomic analyses of lung tissues reveal key genes associated with progression of systemic sclerosis-interstitial lung disease (SSc-ILD).
    Al-Adwi Y; Westra J; van Goor H; van Kempen LC; Osman M; Gan CT; Timens W; Mulder DJ
    J Autoimmun; 2024 Sep; 148():103297. PubMed ID: 39098251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.